Prostate Cancer Trial, Recruiting NCT07112599 Sponsor: Anhui Medical University Condition: Prostate Cancer
Back to Prostate Cancer

Prostate Cancer Trial, Recruiting

NCT07112599
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 50 or older
  • People who have been diagnosed with a specific type of prostate cancer (prostate adenocarcinoma) confirmed through a tissue or cell sample
  • People whose PSA level is 20 ng/ml or higher, or whose cancer has a Gleason score of 8 or higher (a measure of how aggressive the cancer appears)
  • People who are reasonably active and able to care for themselves, as assessed using a standard medical scale (ECOG score of 0–2)
  • People whose doctors estimate they have a life expectancy of at least 6 months
  • People whose blood cell counts are within an acceptable range, showing the bone marrow is functioning adequately
  • People whose liver function test results are within acceptable limits (or within a higher acceptable range if the cancer has spread to the liver)
  • People whose blood clotting function falls within acceptable ranges
  • People whose heart is pumping effectively and whose heart rhythm measurements are within normal limits
  • People whose blood pressure is within normal limits, or whose blood pressure is well-controlled with treatment
  • People whose kidneys are functioning adequately, based on blood and urine tests
  • People who are willing and able to sign a consent form after being informed about the trial
  • People who are able to attend scheduled visits and follow the trial requirements

Who may not be able to join:

  • People who are unable to have an MRI scan, for example due to metal implants in the body or severe fear of enclosed spaces
  • People for whom any required baseline medical or pathology information is missing
  • People with a known history of neurological or psychiatric conditions such as dementia, epilepsy, or seizures
  • People with serious other health conditions that, in the treating doctor's judgement, could affect their safety or ability to complete the trial (such as severe diabetes, thyroid disease, or mental illness), or any personal, family, social, or geographical circumstances that could make following the trial plan difficult
  • People whom the trial investigator considers unsuitable for participation for any reason
  • People who are unable to provide informed consent

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 7 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86 18355159268

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Anhui Medical University
Registry
ClinicalTrials.gov
Start date
25 January 2026
Est. completion
30 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

The area under curve (AUC) of Receiver Operating Characteristic (ROC) curves of the radiopathology artificial intelligence model

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov